Polyarticular Juvenile Idiopathic Arthritis

• CLINICAL_TRIALS trial_result · 2026-02-23
  Clinical Trial Update: Comparative Study of Leflunomide Plus Methotrexate Versus Methotrexate Monotherapy in Refractory Polyarticular Juvenile Idiopathic Arthritis Patients [Phase 4]

  Phase 4 clinical trial comparing leflunomide plus methotrexate versus methotrexate alone in refractory polyarticular juvenile idiopathic art…

• CLINICAL_TRIALS trial_result · 2025-03-24
  Clinical Trial Update: An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediatric Participants With Polyarticular Juvenile Idiopathic Arthritis (pJIA)

  This completed observational study evaluated changes in disease activity and adverse events in Chinese pediatric participants with polyartic…

• CLINICAL_TRIALS trial_result · 2021-02-05
  Clinical Trial Update: Start Time Optimization of Biologics in Polyarticular JIA

  Clinical trial update on start time optimization of biologics in polyarticular juvenile idiopathic arthritis has completed with results post…

• CLINICAL_TRIALS trial_result · 2020-11-18
  Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy [Phase 3]

  Phase 3 study evaluating intravenous golimumab in pediatric patients with active polyarticular juvenile idiopathic arthritis despite methotr…

• CLINICAL_TRIALS trial_result · 2017-06-23
  Clinical Trial Update: Surveillance of Humira in Korean JIA Patients

  A post-marketing safety surveillance study of Humira (adalimumab) in Korean patients with polyarticular juvenile idiopathic arthritis has co…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-03-24
  Clinical Trial Update: Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) [Phase 3]

  Phase 3 trial evaluating pharmacokinetics, efficacy, and safety of subcutaneous abatacept in children with active polyarticular juvenile idi…

• CLINICAL_TRIALS trial_result · 2014-04-16
  Clinical Trial Update: Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis [Phase 2]

  Phase 2 dose-finding trial of givinostat for Polyarticular Juvenile Idiopathic Arthritis was terminated; results were posted in 2014.

• CLINICAL_TRIALS trial_result · 2009-12-23
  Clinical Trial Update: Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) [Phase 3]

  A Phase 3 long-term treatment study of MRA for polyarticular juvenile idiopathic arthritis has completed.

• CLINICAL_TRIALS trial_result · 2008-07-30
  Clinical Trial Update: Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) [Phase 3]

  Phase 3 clinical trial evaluating MRA for polyarticular juvenile idiopathic arthritis has completed.